Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Landay

Showing results (1-10 of 222) with videos related to

Pageof 23
Sort By:
Autoimmunity|March 30, 2012
Effector and regulatory roles for B cells in HIV infection?Basile Siewe, Alan Landay
AIDS (London, England)|April 18, 2003
HIV immunology better understood and vaccination attempts startedBritta Wahren, Alan Landay
Current Infectious Disease Reports|December 29, 2011
Key Concepts in the Early Immunology of HIV-1 InfectionBasile Siewe, Alan Landay
Current HIV/AIDS Reports|April 29, 2010
Early immune senescence in HIV diseaseSeema Desai, Alan Landay
Journal of Hematotherapy & Stem Cell Research|November 13, 2002
Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategiesLena Al-Harthi, Alan Landay
Journal of Leukocyte Biology|October 31, 2009
Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL)Kent W Christopherson, Alan Landay
Current Opinion in HIV and AIDS|April 18, 2009
Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settingsBen Cheng, Alan Landay, Veronica Miller
Cellular Microbiology|March 7, 2016
Microbiome alterations in HIV infection a reviewBrett Williams, Alan Landay, Rachel M Presti
Blood|February 7, 2004
Dynamics of cytokine expression in HIV productively infected primary CD4+ T cellsBouchaib Bahbouhi, Alan Landay, Lena Al-Harthi
Immunology|February 22, 2005
Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cellsElizabeth Z Managlia, Alan Landay, Lena Al-Harthi
Pageof 23

Showing results (1-10 of 222) with videos related to

Sort By:
Pageof 23
Autoimmunity|March 30, 2012
Effector and regulatory roles for B cells in HIV infection?Basile Siewe, Alan Landay
AIDS (London, England)|April 18, 2003
HIV immunology better understood and vaccination attempts startedBritta Wahren, Alan Landay
Current Infectious Disease Reports|December 29, 2011
Key Concepts in the Early Immunology of HIV-1 InfectionBasile Siewe, Alan Landay
Current HIV/AIDS Reports|April 29, 2010
Early immune senescence in HIV diseaseSeema Desai, Alan Landay
Journal of Hematotherapy & Stem Cell Research|November 13, 2002
Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategiesLena Al-Harthi, Alan Landay
Journal of Leukocyte Biology|October 31, 2009
Liver X receptor alpha (LXRalpha) as a therapeutic target in chronic lymphocytic leukemia (CLL)Kent W Christopherson, Alan Landay
Current Opinion in HIV and AIDS|April 18, 2009
Research needs and challenges in the development of HIV diagnostic and treatment monitoring tests for use in resource-limited settingsBen Cheng, Alan Landay, Veronica Miller
Cellular Microbiology|March 7, 2016
Microbiome alterations in HIV infection a reviewBrett Williams, Alan Landay, Rachel M Presti
Blood|February 7, 2004
Dynamics of cytokine expression in HIV productively infected primary CD4+ T cellsBouchaib Bahbouhi, Alan Landay, Lena Al-Harthi
Immunology|February 22, 2005
Interleukin-7 signalling is sufficient to phenotypically and functionally prime human CD4 naive T cellsElizabeth Z Managlia, Alan Landay, Lena Al-Harthi
Pageof 23